A systematic review of 38 studies found that digital health interventions can help patients with coronary artery disease improve medication adherence and lifestyle behaviors, though the strength of evidence varies across intervention types.
Researchers conducted a comprehensive evidence summary of digital health interventions designed to support self-management in coronary artery disease (CAD) patients. They searched six major medical databases from inception through November 2025 and included 38 studies: six clinical guidelines, 13 systematic reviews, 15 randomized controlled trials, and four quasi-experimental studies. The analysis synthesized evidence across five key domains: intervention modalities, self-management support strategies, medication adherence, lifestyle management, and clinical outcomes.
Digital health interventions took multiple forms in the included studies. These ranged from mobile applications and web-based platforms to remote monitoring systems and telehealth consultations. The review examined how these tools supported CAD patients in managing their condition between clinical visits. Rather than prescribing a single technology, the evidence pointed to several effective approaches: some studies used apps that tracked medications and symptoms, others delivered personalized education and behavioral coaching, and some combined monitoring with direct clinician feedback.
The evidence summary identified particularly strong findings in two areas. First, digital interventions showed benefit for medication adherence, a critical factor since CAD patients typically require multiple medications long-term. Second, lifestyle management tools demonstrated measurable effects on physical activity levels and dietary adherence, both core components of CAD self-management. The review noted that interventions combining education, behavioral support, and tracking functionality appeared more effective than single-component approaches. However, the certainty of evidence differed across studies, with variation in study design quality and outcome measurement methods.
The authors emphasized that effective digital interventions shared certain characteristics: they were tailored to individual patient needs rather than generic, they provided regular feedback or reinforcement, and they integrated with existing clinical care pathways rather than operating in isolation. The review also highlighted gaps in current evidence, including limited long-term follow-up data, insufficient diversity in study populations, and unclear cost-effectiveness data across healthcare systems.
If you have coronary artery disease or are recovering from a cardiac event, this evidence summary suggests several practical points to consider:
Digital tools are most useful when targeted to your specific challenges. Generic CAD apps may be less helpful than systems designed around your particular medication regimen, dietary preferences, or exercise capacity. If your clinician recommends a digital tool, asking whether it's been evaluated in research studies similar to your situation is reasonable.
Combination approaches work better than single features. An app that only logs your steps will likely have less impact than one integrating education, symptom tracking, medication reminders, and feedback from your healthcare team. Look for platforms that address multiple aspects of self-management.
Integration with your clinical team matters. Digital tools that sit isolated on your phone without connection to your cardiologist or primary care provider show less consistent benefit. The best evidence comes from systems where your provider can actually see your data and respond.
Adherence tools can have real impact. If medication compliance has been challenging, digital reminders, tracking, or feedback systems have evidence supporting their use in CAD populations specifically. This is one area where the research base is relatively strong.
Long-term outcomes remain less clear. While short-term studies show improvements in adherence and lifestyle behaviors, the review notes limited data on whether digital interventions reduce long-term complications, hospitalizations, or mortality in CAD patients. The immediate effects on behavior are better established than ultimate health outcomes.
| Characteristic | Details |
|---|---|
| Study type | Systematic review and evidence summary (JBI methodology) |
| Records screened | 5,312 |
| Studies included | 38 (6 guidelines, 13 systematic reviews, 15 RCTs, 4 quasi-experimental) |
| Key domains assessed | Intervention modalities, self-management support, medication adherence, lifestyle management, clinical outcomes |
| Evidence evaluation | GRADE approach for certainty and strength of recommendations |
| Database period | Inception through November 2025 |
| Journal | Frontiers in Public Health |
| Registration | PROSPERO (CRD420251228969) |
Frontiers in Public Health. Digital health interventions for self-management in coronary artery disease. PubMed: 42404963
ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.